Clinical Trial Update: Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of avatrombopag in cancer patients with thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Thrombocytopenia, Avatrombopag | Phase 2 | Status: UNKNOWN